Concepedia
Statistics
Publications
6
Citations
605
H-Index
Active since
1998
Affiliations
Astellas Pharma (Japan)(Current)
Tokyo University of Science
The University of Tokyo
Kenna Shirasuna is an author at Astellas Pharma (Japan) specializing in medicine, cell biology, and molecular biology.
Top concepts
MedicineCell BiologyUrologyCell DeathPharmacologyTumor BiologyCell SignalingDrug ResistanceGene ExpressionGene Regulation
Publications per year
1998–2021
YM155, a Novel Small-Molecule Survivin Suppressant, Induces Regression of Established Human Hormone-Refractory Prostate Tumor Xenografts
Takahito Nakahara, Masahiro Takeuchi, Isao Kinoyama et al. · Cancer Research · 2007 · 502 citations
Urology, Induces Regression, Chemoprevention Strategy +14
A novel E2F binding protein with Myc-type HLH motif stimulates E2F-dependent transcription by forming a heterodimer
Mitsuhiro Suzuki, Satoshi Okuyama, Satoru Okamoto et al. · Oncogene · 1998 · 43 citations
Transcriptional Regulation, Signal Transduction, Signaling Pathway +13
YM-359445, an Orally Bioavailable Vascular Endothelial Growth Factor Receptor-2 Tyrosine Kinase Inhibitor, Has Highly Potent Antitumor Activity against Established Tumors
Nobuaki Amino, Yukitaka Ideyama, Mayumi Yamano et al. · Clinical Cancer Research · 2006 · 24 citations
Characterization of ASP8374, a fully-human, antagonistic anti-TIGIT monoclonal antibody
Kenna Shirasuna, Gerald Koelsch, Cynthia Seidel‐Dugan et al. · Cancer Treatment and Research Communications · 2021 · 15 citations · Full text
Correlation analysis of the proportion of monocytic myeloid-derived suppressor cells in colorectal cancer patients
Kenna Shirasuna, Masayuki Itô, Takashi Matsuda et al. · PLoS ONE · 2020 · 11 citations · Full text
1–5 of 6